Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Milk Samples of Dairy Cows with Mastitis in Bavaria, Germany

Microb Drug Resist. 2018 May;24(4):505-510. doi: 10.1089/mdr.2017.0182. Epub 2017 Sep 27.

Abstract

The aim of this study was to determine the rate of extended-spectrum β-lactamase (ESBL)-producing microorganisms among Escherichia coli isolates causing bovine mastitis, including molecular characterization of these isolates. Therefore, a total of 490 bovine E. coli isolates from milk samples of dairy cows with mastitis were investigated for ESBL production by antimicrobial susceptibility testing, PCR-based detection, and sequencing of ESBL encoding genes, which were identified in 22 isolates (4.5%). Moreover, resistance to the fluoroquinolones enrofloxacin and marbofloxacin occurred in 15 of 22 ESBL-producing isolates (68.2%). All ESBL-producing isolates carried a blaCTX-M-like gene, with blaCTX-M-14 (n = 10) as the most prevalent type. Seven isolates producing CTX-M-14 and belonging to phylogenetic group A were further investigated for genetic relatedness by multilocus sequence typing. Five of them could be assigned to four different sequence types (STs): ST10 (n = 2), ST167 (n = 1), ST410 (n = 1), and ST744 (n = 1), whereas the remaining two isolates could not be assigned. To conclude, the rate of ESBL-producing E. coli associated with cattle mastitis was 4.5%. Furthermore, a high proportion of fluoroquinolone coresistance could be detected. Therefore, careful and continuous surveillance of ESBL-producing E. coli in cattle and consequent implementation of prevention measures are needed to avoid a further spread of these multidrug-resistant bacteria.

Keywords: ESBL; Escherichia coli; bovine mastitis; molecular characterization; prevalence.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Typing Techniques / methods
  • Cattle
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Drug Resistance, Multiple, Bacterial / genetics
  • Enrofloxacin
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development*
  • Escherichia coli / isolation & purification*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Female
  • Fluoroquinolones / pharmacology
  • Germany
  • Mastitis, Bovine / microbiology*
  • Milk / microbiology*
  • Multilocus Sequence Typing / methods
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Enrofloxacin
  • marbofloxacin
  • beta-Lactamases